FDA head “very committed” to moving forward on CBD.

How? Robert Califf said he is not sure. It will take work and “some creativity,” the commissioner said during a Capitol Hill hearing. Find out why U.S. Hemp Roundtable general counsel Jonathan Miller was encouraged by his remarks at Natural Products Insider.

CBD brands get creative with sampling.

Now that events—and in-person shopping—are returning, learn how manufacturers of products featuring CBD are finding ways to make product sampling work around legal barriers, age restrictions and public-consumption bans. Read more at MJBizDaily.

FDA issues more warning letters.

In May, the agency issued letters to four companies illegally selling CBD products intended for use in food-producing animals as well as warning letters to five companies for selling products labeled as containing delta-8 tetrahydrocannbinol (delta-8 THC) in ways that violate the Federal Food, Drug and Cosmetic Act. It was the first time FDA has issued warning letters for products containing delta-8 THC. Get the scoop here and here:

Could a Senate Act lead to the removal of CBD from the market?

Natural Products Association (NPA) President and CEO Dan Fabricant believes so. Find out why he calls draft legislation “radical and dangerous,” which, if passed could lead to mandatory product listing—and the removal of ingredients such as NAC and CBD from shelves at Natural Products Insider.

With AI and deep pockets, Brightseed explores fat-fighting power of hemp.

Fueled by $120 million in funding, the company is on a mission to unlock the hidden healing potential of plants by finding active compounds to target specific conditions that currently have no treatment, such as non-alcoholic fatty liver disease. Find out more at Forbes.